Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Amoxicillin and Metronidazole Plus Bismuth for H. pylori
NCT03557437Phase 4Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- May 2018
- Primary completion
- Jun 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of bismuth subcitrate in Helicobacter pylori infection, sponsored by Shanghai Jiao Tong University School of Medicine. Started May 2018; status: completed.
02
Drugs
bismuth subcitrate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03557437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03557437.